chr6-149244850-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000635954.1(ENSG00000228408):​n.1489T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.804 in 151,532 control chromosomes in the GnomAD database, including 49,063 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.80 ( 49037 hom., cov: 27)
Exomes 𝑓: 0.80 ( 26 hom. )

Consequence

ENSG00000228408
ENST00000635954.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.19

Publications

0 publications found
Variant links:
Genes affected
TAB2 (HGNC:17075): (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
TAB2-AS1 (HGNC:53508): (TAB2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.06).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.931 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAB2NM_001292035.3 linkc.6+26074T>C intron_variant Intron 2 of 6 NP_001278964.1 Q9NYJ8B4DIR9
TAB2-AS1NR_149096.1 linkn.169-849A>G intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000228408ENST00000635954.1 linkn.1489T>C non_coding_transcript_exon_variant Exon 4 of 4 5
TAB2ENST00000606202.1 linkc.-121+26074T>C intron_variant Intron 1 of 1 4 ENSP00000476139.1 U3KQR0
TAB2-AS1ENST00000424421.3 linkn.175-849A>G intron_variant Intron 1 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.804
AC:
121596
AN:
151332
Hom.:
48993
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.849
Gnomad AMI
AF:
0.955
Gnomad AMR
AF:
0.858
Gnomad ASJ
AF:
0.758
Gnomad EAS
AF:
0.954
Gnomad SAS
AF:
0.718
Gnomad FIN
AF:
0.714
Gnomad MID
AF:
0.794
Gnomad NFE
AF:
0.772
Gnomad OTH
AF:
0.810
GnomAD4 exome
AF:
0.805
AC:
66
AN:
82
Hom.:
26
Cov.:
0
AF XY:
0.796
AC XY:
43
AN XY:
54
show subpopulations
African (AFR)
AF:
1.00
AC:
4
AN:
4
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.500
AC:
1
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
0.500
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
0.803
AC:
53
AN:
66
Other (OTH)
AF:
0.875
AC:
7
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.804
AC:
121698
AN:
151450
Hom.:
49037
Cov.:
27
AF XY:
0.800
AC XY:
59191
AN XY:
73966
show subpopulations
African (AFR)
AF:
0.849
AC:
34974
AN:
41208
American (AMR)
AF:
0.859
AC:
13081
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.758
AC:
2629
AN:
3470
East Asian (EAS)
AF:
0.954
AC:
4909
AN:
5148
South Asian (SAS)
AF:
0.718
AC:
3445
AN:
4800
European-Finnish (FIN)
AF:
0.714
AC:
7440
AN:
10418
Middle Eastern (MID)
AF:
0.793
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
0.772
AC:
52414
AN:
67858
Other (OTH)
AF:
0.808
AC:
1704
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1169
2338
3506
4675
5844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
868
1736
2604
3472
4340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.789
Hom.:
5924
Bravo
AF:
0.823
Asia WGS
AF:
0.802
AC:
2791
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.1
CADD
Benign
0.77
DANN
Benign
0.14
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7747474; hg19: chr6-149565986; COSMIC: COSV70064225; API